Article

Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222

2021-07-18

Abstract excerpt

<h4>Background</h4> While there have been many studies characterizing the IgG and IgA responses to different SARS-CoV-2 proteins in individuals with natural infection, the induction of IgG and IgA to different viral proteins in vaccinees have not been extensively studied. Therefore, we sought to investigate the antibody responses to SARS-CoV-2 following natural infection and following a single dose of AZD2221, in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e1136976-1319-55b3-8f78-443bd1fd12b5
DOI: 10.1101/2021.07.14.21260510

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222DOI 10.1101/2021.07.14.21260510Read

Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countriesSemantic proximity Read

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individualsSemantic proximity Read

Antibody response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in TaiwanSemantic proximity Read

Comparison of the Immunogenicity of five COVID-19 vaccines in Sri LankaSemantic proximity Read

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Mucosal and systemic responses to SARS-CoV-2 vaccination in infection naïve and experienced individualsSemantic proximity Read

Cohort Profile: The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)Semantic proximity Read

Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity Read

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022Semantic proximity Read

Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1Semantic proximity Read

Phase 1 Study of Safety, Reactogenicity, and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate Administered as Inhalation Boost in SARS-CoV-2 Immunized AdultsSemantic proximity Read